The Hemp Guardrails Act: The Protections Are Real. So Are the Risks.
A new Senate bill takes real steps to keep hemp products away from kids. It also creates new legal risks for anyone under 21, and for the businesses that grow, make and sell hemp.
Kids should not have intoxicating hemp products, and on that point the Hemp Guardrails Act is right. The bill, filed in the Senate on November 17, would set an age limit of 21 and require child-resistant packaging, warning labels and lab testing. For adults, it would keep delta-9 THC products legal as hemp, and the bill sets no milligram limit on how much THC a container can hold.
The risks sit in two places.
For young people, the bill does more than tell stores not to sell to anyone under 21. It makes it against federal law for the person under 21 to have the product. When a sale happens anyway, the business has broken the law, and so has the kid.
For operators, the people who grow, make and sell hemp, the bill would take effect on December 11, 2026. The FDA would have up to 180 days after it becomes law to write the rules they must follow.
Because of those risks, Drug Policy Watch does not support the bill as written.
Read the rest, free
Enter your email to open the full story and get the weekly brief: the hemp rules, the hearings, the money. No charge. Unsubscribe anytime.
Already subscribe? Enter the same address.
We never sell your address. After you sign up, look for a confirmation email, and check your spam folder if you do not see it. Privacy
First, the background
Hemp is the cannabis plant grown with very little THC, the compound that gets people high. Since 2018, federal law has treated hemp as a legal crop. That is why hemp gummies, hemp drinks and CBD oils are sold in so many stores. (How that happened.)
Last year Congress changed the rules. A new law narrows what counts as hemp. This September a second law pushed most of it back, so the limits arrive in two steps. The first took effect on November 12, 2026. The second arrives on December 11, 2026, and it includes a limit of 0.4 milligrams of THC in a whole container. (Our explainer on the two dates.)
The Hemp Guardrails Act is one answer to that deadline. Sen. Tim Sheehy, a Republican from Montana, introduced it with Sen. Amy Klobuchar, a Democrat from Minnesota. Its number is S. 5736, and it has been sent to the Senate's health committee.
It is a bill, not a law. Nothing about what is legal today has changed.
Congress has not published the official text yet. We read the 17-page draft the senators released, which has a blank where the bill number goes. When the official version posts, we will compare the two word for word and say here what changed, if anything.
What the bill would do
- Raise the line for the crop to 1.0 percent total THC. Total THC counts THCA along with delta-9. The federal rule growers are tested under already counts both, at 0.3 percent, so a crop that tests between 0.3 and 1.0 percent would count as hemp under the bill. A crop high in THCA would still be over the line.
- Keep delta-9 THC products legal as hemp, with no milligram cap. The 0.4 milligram per container limit would be deleted on the day it is set to start. The bill puts no milligram limit in its place, per container or per serving. The 1.0 percent line still applies to hemp, and whether it limits a finished product is not settled.
- Restrict other intoxicating compounds, but not delta-9. A finished product with more than "trace amounts" of delta-8, delta-10, HHC, THC-O or other compounds that intoxicate the same way would not count as hemp. Delta-9, the ordinary THC, is exempt by name. So are CBD and five other compounds.
- Put the FDA in charge of hemp products. The agency would have 180 days to write rules on packaging, labels, testing, recalls and registering the places that make these products.
- Keep flower from crossing state lines. Products that contain raw hemp flower, smokable flower or pre-rolls could not be shipped from one state to another.
- Require American-made. Every step, from the farm to the label, would have to happen in the United States.
- Set 21 as the age. Stores could not sell to anyone under 21. And anyone under 21 could not have or use these products. That second part is the first risk below.
The protections
The warnings and the ban on child-style packaging are written into the bill itself. The other three would arrive when the FDA writes its rules.
- child-resistant packaging;
- warnings against use by children;
- no packaging that copies the images used to advertise to children;
- testing by outside labs, with results a buyer can look up from the label;
- rules for pulling a bad product off the shelf.
Those protect a child at home.
Who the bill helps, and who it hurts
This is our reading of what the text would do to each group if it became law as written. It is not a forecast of who wins or loses in the market.
Who it helps
- Makers of manufactured delta-9 products. Drinks, gummies, tinctures, capsules and vapes would stay legal as hemp, with no milligram cap, no tax, no fee and no license.
- Makers of hemp drinks. Beverages are on the bill's product list by name. Sen. Klobuchar's statement on the bill names brewers among those she says "a looming federal ban on hemp products" is threatening.
- Makers of CBD supplements. The bill creates a supplement category, and on our reading it lifts the bar that has kept CBD out of supplements.
- Growers whose crops test between 0.3 and 1.0 percent total THC.
- U.S. growers and processors. Every step must happen in the United States, which would keep out products made with hemp grown or processed abroad.
- A child at home. The packaging, warning and testing rules above.
Who it hurts
- Anyone under 21. Having a hemp product would be against federal law, even one that cannot get anyone high, on our reading.
- Flower growers and the shops that sell flower. Smokable flower and pre-rolls could not cross state lines. That bar is new in this bill. A crop high in THCA would still fall outside hemp, which the bill does not change.
- Makers and sellers of delta-8, delta-10, HHC and THC-O products. More than a trace, and the product is not hemp. The bill would lift last year's limits for delta-9 products and write a new one for these.
- Anyone holding a product the bill leaves outside hemp. Our reading, the same one we published in July about last year's law: a product outside the definition falls under federal drug law, where knowingly having it is an offense at any age (21 U.S.C. 844). That exposure is already set by last year's law. The bill would narrow it for delta-9 products and leave it in place for the rest.
- Operators holding stock made with hemp grown or processed abroad. The bill has no grace period for it.
Not known yet: small makers. Nothing in the bill is scaled by size, and the rules that would set their costs are not written.
Risk one: the rule lands on the young person
Federal food and drug law keeps a list called "prohibited acts". It means what it sounds like: things it is against federal law to do. This bill adds six entries to that list. Two are about age.
The first bars selling a hemp product to anyone under 21. That is the right rule, and our own hemp principles call for an age line at the register. The store has the duty, the same way it does with tobacco.
The second is this, word for word:
"The possession or consumption of a hemp-derived cannabinoid product by any person younger than 21 years of age."
Now the person breaking the rule is not the store. It is the 20-year-old. It is also the 16-year-old, because the sentence has no lower age.
Three things about that sentence, each checked against the text:
The sentence has no exceptions. We searched the whole bill for the words medical, parent and prescription. None of them appears.
- medical0
- parent0
- prescription0
It likely covers products that cannot get anyone high. The bill's description of a hemp product takes in drinks, tinctures, capsules and products for the skin, and it has no carve-out for CBD. That is our reading of the definition. The bill does not say it in so many words.
It is not new. The same sentence, word for word, is in H.R. 9830, a House hemp bill filed in July. We wrote about it then. At least two bills in Congress now carry it.
The senators say so themselves. Each senator's own press release says the bill prohibits "the sale, possession, and consumption of consumable hemp products by individuals under 21".
What could happen to a young person
What the bill says and what we think it means are two different things, so we keep them apart.
What the bill says. Nothing. It sets no punishment for this. It also does not touch the part of food and drug law that sets punishments. We searched, and the bill never mentions that part.
What we think that means. Food and drug law already has a general penalty for anything on the prohibited list. Because the bill leaves it alone, the general penalty would apply. For a first violation, that is up to one year in prison, a fine, or both. The fine printed in that old section is $1,000, but a newer law raises the ceiling for this kind of offense to $100,000. A second violation after a conviction, or one done with intent to defraud or mislead, can bring up to three years, which makes it a felony, with a fine ceiling of $250,000.
No lawyer has reviewed that reading. It is the same one we published in July for the identical sentence. And it comes with limits that matter as much as the numbers do.
- People under 18 are handled differently. Federal law sends those cases to state authorities unless the Attorney General certifies otherwise.
- It may not reach a person who only has a product. That is an open legal question, and if the answer is no, the sentence would be a rule with no penalty behind it.
- These are maximums. A ceiling is not a sentence, and it is not a prediction.
- We are not predicting prosecutions. What a law allows and what agencies do are different things, and in July we wrote that federal cases against individual consumers would be rare.
- The FDA can answer with a warning. For a small violation, the law lets the agency send a written notice instead.
- There is no civil fine route. Tobacco has one in this same law. The bill writes none for hemp products, though court orders and product seizures are civil.
- Intent is an open question. We know of no court ruling on whether the government would have to prove that a person who only possesses a product meant to break the law.
Risk two: operators would face rules that are not written yet
The bill does real things for operators. It has no tax, no fee and no license, and it stops a state or tribe from blocking a product that follows the federal rules from passing through.
The main risk is timing. Everything in the bill takes effect on December 11, 2026, and the FDA then has up to 180 days after the bill becomes law to write the rules on packaging, labels, testing, manufacturing, recalls and registration. That leaves a stretch, up to 180 days if the FDA meets its deadline, when the law is in force and the rulebook is not written. The bill has no fallback if the agency misses the deadline.
Not to scale. Up to 180 days if the FDA meets its deadline.
Six more risks follow. Each one is in the text, or marked as our reading.
- Some rules would not wait. Several things would be against federal law as soon as the bill took effect. Among them: selling to anyone under 21, sending a product with flower in it across state lines, and sending one that was not grown, processed, packaged and labeled in the United States. The label and packaging terms written into the bill itself, such as warnings against use by children, would also apply from that day. The bill has no grace period for stock already made.
- Failing to register would become a prohibited act, and the registration rules are not written. The bill adds its rules section to the existing federal ban on failing to register. Whether anything could be charged before the FDA writes those rules is an open question. That is our reading.
- The bill has no defense for a seller who checked ID. We searched the bill for a defense for a seller who checked proof of age. There is none.
- One undefined phrase decides what counts as hemp. A finished product with more than "trace amounts" of delta-8 and similar compounds is not hemp. The bill does not define the phrase or say who decides.
- Nothing is scaled by size. The word small does not appear in the bill. What the FDA's rules would cost a small maker cannot be known until they are written.
- The penalty for a seller is the same default. On our reading, the general penalty described above would apply to a business that sells to someone under 21, and for a company the fine ceilings are double. The FDA could also seize products and inspect facilities. Unlike tobacco, there is no civil fine route.
Is the under-21 rule normal?
Partly yes, and that should be said first. States do set rules for young people. When we checked six states' hemp laws in July, three had a rule that reaches the young person. One makes it a crime and leaves CBD out, one writes a small ticket kept off the record, and one only takes the product away. States we have read, among them North Carolina, Oregon and West Virginia, have a rule against someone under 21 having alcohol, and Oregon has one for marijuana.
Congress has handled age 21 differently in its own laws. The federal tobacco law puts the duty on the store. The federal drinking-age law works by holding back highway money from states. No act of Congress has ever made a minor's possession of alcohol a federal offense nationwide; the closest federal rule is a National Park Service regulation on federal land that defers to state law.
- Federal tobacco lawThe store
- Federal drinking-age lawStates, through highway money
- This billThe store, and the person under 21
So what stands out is the shape of the bill's under-21 sentence. It has no lighter track for the youngest, no exception for a parent or a doctor, and no protection for someone who calls for help.
What else to know
States and tribes. They could pass stricter rules, but could not block a compliant product from passing through. The clause that protects state and tribal laws names producing, making, distributing, importing and selling. It does not name possession or use. What that silence means is not settled.
Medicare. The bill says it does not limit two things: a Medicare program involving hemp supplements, and the government's power to let Medicare Advantage plans cover them. It creates no coverage and adds no money.
Potency. Whether the FDA could set a milligram limit by rule is not settled.
Who has said they support it
The sponsors. Sen. Klobuchar's statement says "a looming federal ban on hemp products is threatening farmers, brewers, small businesses, and consumers across Minnesota and the country".
A hemp trade group. Jonathan Miller, general counsel for the U.S. Hemp Roundtable, said that "all responsible players in the hemp industry are united in support" of the bill, as quoted by Marijuana Moment. The same article reports that he said the group looks forward to working with the two senators to secure the provisions' "inclusion in the next spending bill or continuing resolution".
What the money records show
We searched the lobbying and contribution records we hold for any mention of this bill. There is none.
- Lobbying reports. The lobbying filings we hold run through September 2026, before the bill was introduced. None names it. The first quarterly reports that could are due January 20, 2027.
- Contribution reports. Lobbyists and the groups that employ them also report their political contributions. Those reports list payments and dates. They do not name bills, so they cannot show who asked for one.
So the records we hold do not show whether anyone asked the senators for this bill. When the January reports post, we will read them and report what they say.
Where we stand
Drug Policy Watch does not support this bill as written. Our reasons come from the text.
- In our view, it draws its line by product, not by risk. Manufactured delta-9 products, drinks among them, stay legal as hemp with no milligram cap. The plant's own flower cannot cross state lines.
- It puts the law on people. Anyone under 21 who has a hemp product would break federal law. And on our reading, the bill leaves in place the drug-law exposure that last year's law sets for anyone holding a product outside hemp.
- It starts before its rules exist. Operators would be bound on December 11, before the FDA has written the rulebook.
We credit the protections for children, and we support an age line at the register.
What you can do
This is a bill, not a law, and its words can still change. Two dates set the clock. The bill's own start date is December 11, 2026. This Congress ends on January 3, 2027, and a bill that has not passed both the House and the Senate by then dies.
- The bill's own start dateDecember 11, 2026
- This Congress endsJanuary 3, 2027
If you want the protections without the risks, ask your two senators for four changes.
- Take the law off the person. Strike the line that makes it against federal law for anyone under 21 to have a hemp product. Keep the ban on selling to them.
- Protect flower and the farms that grow it. Remove the bar on flower crossing state lines. The plant's own flower should not be shut out while manufactured products that follow the federal rules are let through.
- Write the rules before the start date. Operators should get the FDA rulebook, and time to meet it and to sell existing stock, before anything can be charged.
- Set a real dose limit. The bill removes the only milligram cap in federal hemp law and puts no milligram limit in its place.
Disclosure. Drug Policy Watch is involved in Open Materia, a project that publishes its own framework for cannabis regulation, and the changes we ask for here draw on our own policy work.
Our guide, How to Be Heard, shows how to reach your senators. Tell them who you are and what this bill would do to you. You do not have to say what you use, hold or sell. Share only what you are comfortable telling a government office. If you are under 18, ask a parent or guardian to contact the office with you.
A bill can protect kids without making them lawbreakers. It can hold an industry to rules after it writes them. Ask for that bill.
About the author. Jessica Mantonya is the founder of Drug Policy Watch and Hold in Common, an independent, non-captured tracker of cannabis, hemp, and psychedelic policy across the federal government and all fifty states. A longtime patient-access advocate, she follows the money and the paperwork to show how the plant is being fenced off, and how to keep it in the commons.
Sources
- S. 5736, GPO bill status record and Congress.gov, checked November 19, 2026. No official text was posted on that date.
- Hemp Guardrails Act, draft text released by the sponsors, 17 pages.
- Sen. Sheehy's release and Sen. Klobuchar's release, November 17, 2026.
- Marijuana Moment, November 17, 2026: the source of the U.S. Hemp Roundtable quotation.
- Public Law 119-37, Section 781: last year's law, including the 0.4 milligram limit.
- Public Law 119-103, Section 2019: the September 2026 law that set the two dates.
- 7 CFR part 990, USDA's rule for hemp growers: crops are tested on total THC, which counts THCA.
- H.R. 9830, and our July 30 brief, The Hemp Bill That Would Make the Kid the Offender.
- The prohibited acts list, 21 U.S.C. 331. The general penalty, 21 U.S.C. 333. Written notice for small violations, 21 U.S.C. 336.
- The fine ceilings, 18 U.S.C. 3571, and the offense classes, 18 U.S.C. 3559.
- Drug possession, 21 U.S.C. 844. Juvenile cases, 18 U.S.C. 5032.
- The tobacco sales age, 21 U.S.C. 387f(d)(5). The drinking-age law, 23 U.S.C. 158. The park regulation, 36 CFR 2.35.
- Lobbying and contribution reports filed under the Lobbying Disclosure Act, at lda.gov. Our copies were pulled in late October 2026. We searched them, and the live lobbying filings, on November 19, 2026.
- Drug Policy Watch holds saved, fingerprinted copies of the senators' draft, both of their press releases, the House bill and last year's law, so these citations survive if a page moves.
How we checked
We read the senators' 17-page draft, then matched our read against a machine copy of the same file. Every quotation here was checked against a saved copy of its source: the bill, the two senators' press releases, or the Marijuana Moment article. When we say a word is not in the bill, we searched for it, and we ran the same search on a word we knew was there, to be sure the search worked. The bill's number, sponsor, committee and status come from the Government Publishing Office's record.
Corrections. We correct errors in public, on the same page as the error, with the date and a note saying what changed. We do not quietly edit and we do not pretend it did not happen. Our full corrections policy and our permanent correction log are here. If we have something wrong, tell us: contact@drugpolicywatch.info. Tell us which line, and tell us what is wrong with it. We will look at it the day it arrives. If you are one of the people or organizations named in this article and you want to respond, we will publish your response in full and unedited, on this page. Not a summary. The whole thing, in your words.
License. This article is free to share and adapt for non-commercial purposes, with credit, under CC BY-NC-SA 4.0. Copyright in the original text is held by Jessica Mantonya, doing business as Drug Policy Watch. "Drug Policy Watch"™ and its logo are common-law marks. Public records are not ours to license. The underlying statutes, bills and lobbying filings are government records. Not everything is under this license. The full fifty-state briefs, the live legislative trackers, and our other research and data products are separately licensed and are not covered by CC BY-NC-SA. See Terms & License.
This is journalism and analysis, not legal, regulatory or financial advice, and not an official government position. If a decision turns on a specific law or filing, confirm it on the linked source and consult counsel for your situation.